Clinical trial · Observational
Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule
LOw Grade Serous Ovarian Carcinoma and Uterine Involvement : Should hYSTerectomy be the Rule
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Investigators studied a population of 28 low grade serous ovarian carcinoma treated in Hospices civils de Lyon between 2000 and 2022. The primary objective is to determinate the rate of myometrial involvement by the cancer at pathology examination. Then, investigators compared patients with or without myometrial involvement : survival parameters, predictive factors of myometrial involvement (age, CA 125 level, surgery characteristics, pathology characteristics).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Low Grade Serous Ovarian Carcinoma | — | UNRESOLVED | — |
| Serous Ovarian Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma. | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Myometrial involvement
- description
- Myometrial involvement by cancer metastasis after pathology examination
- interventionNames
- Other: Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
- label
- No myometrial involvement
- description
- Absence of myometrial involvement by cancer metastasis after pathology examination
- interventionNames
- Other: Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
Primary outcomes (1)
- measure
- Percentage of myometrial involvement
- timeFrame
- After pathology examination, average 2 to 3 weeks after cytoreductive surgery
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
* Inclusion Criteria : * 18 years old or more * low grade serous ovarian cancer (MDACC classification) * Grade 1 serous ovarian carcinoma (Silverberg classification) * Exclusion Criteria : * no sufficient data available * grade 2 and 3 serous ovarian carcinoma
References
Publications (0)
Data not yet available